Kyverna Therapeutics
KYTX
#7325
Rank
C$0.64 B
Marketcap
C$10.84
Share price
9.08%
Change (1 day)
143.66%
Change (1 year)

Kyverna Therapeutics (KYTX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$48.13 Million

According to Kyverna Therapeutics's latest financial reports the company's total liabilities are C$48.13 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Kyverna Therapeutics - Total liabilities on balance sheet (from 2022 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$54.61 M-80.07%
2023-12-31C$0.27 B43.3%
2022-12-31C$0.19 B13.89%
2021-12-31C$0.16 B